Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bednarczyk

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Clinical Chemistry|February 1, 1988
Improved receptor assay for measuring digoxin activityB Bednarczyk, S J Soldin, I Gasinska, et al.
Chemico-Biological Interactions|September 13, 2015
Proapoptotic activity and ABCC1-related multidrug resistance reduction ability of semisynthetic oleanolic acid derivatives DIOXOL and HIMOXOL in human acute promyelocytic leukemia cellsA Paszel-Jaworska, B Rubiś, B Bednarczyk-Cwynar, et al.
Kardiologia Polska|January 1, 1984
[Preliminary studies of the adrenergic receptors in the human right atrium]J Vetulani, L Antkiewicz-Michaluk, B Bednarczyk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2012
Discovery of a novel Toxoplasma gondii conoid-associated protein important for parasite resistance to reactive nitrogen intermediatesSini Skariah, Robert B Bednarczyk, Matthew K McIntyre, et al.
Oncotarget|June 1, 2018
Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancerRobert B Bednarczyk, Neha Y Tuli, Elyse K Hanly, et al.
Oncotarget|January 7, 2016
Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cellsElyse K Hanly, Neha Y Tuli, Robert B Bednarczyk, et al.
Elife|September 11, 2024
Targeting ribosome biogenesis as a novel therapeutic approach to overcome EMT-related chemoresistance in breast cancerYi Ban, Yue Zou, Yingzhuo Liu, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Targeting Ribosome Biogenesis as a Novel Therapeutic Approach to Overcome EMT-related Chemoresistance in Breast CancerYi Ban, Yue Zou, Yingzhuo Liu, et al.
Oncotarget|August 19, 2015
mTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenibElyse K Hanly, Robert B Bednarczyk, Neha Y Tuli, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Chemistry|February 1, 1988
Improved receptor assay for measuring digoxin activityB Bednarczyk, S J Soldin, I Gasinska, et al.
Chemico-Biological Interactions|September 13, 2015
Proapoptotic activity and ABCC1-related multidrug resistance reduction ability of semisynthetic oleanolic acid derivatives DIOXOL and HIMOXOL in human acute promyelocytic leukemia cellsA Paszel-Jaworska, B Rubiś, B Bednarczyk-Cwynar, et al.
Kardiologia Polska|January 1, 1984
[Preliminary studies of the adrenergic receptors in the human right atrium]J Vetulani, L Antkiewicz-Michaluk, B Bednarczyk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2012
Discovery of a novel Toxoplasma gondii conoid-associated protein important for parasite resistance to reactive nitrogen intermediatesSini Skariah, Robert B Bednarczyk, Matthew K McIntyre, et al.
Oncotarget|June 1, 2018
Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancerRobert B Bednarczyk, Neha Y Tuli, Elyse K Hanly, et al.
Oncotarget|January 7, 2016
Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cellsElyse K Hanly, Neha Y Tuli, Robert B Bednarczyk, et al.
Elife|September 11, 2024
Targeting ribosome biogenesis as a novel therapeutic approach to overcome EMT-related chemoresistance in breast cancerYi Ban, Yue Zou, Yingzhuo Liu, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Targeting Ribosome Biogenesis as a Novel Therapeutic Approach to Overcome EMT-related Chemoresistance in Breast CancerYi Ban, Yue Zou, Yingzhuo Liu, et al.
Oncotarget|August 19, 2015
mTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenibElyse K Hanly, Robert B Bednarczyk, Neha Y Tuli, et al.
Pageof 2